McCormick director Gavin Hattersley acquires $44,610 in common shares
Bitget2026/10/05 17:15McCormick director Gavin Hattersley bought 1,000 shares of common stock – non voting at $44.61. His holdings in the class rose to 3,906 shares. He reported 406 shares of common stock – voting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McCormick & Company Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000063754-26-000331), on October 05, 2026, and is solely responsible for the information contained therein.
- McCormick director Gavin Hattersley bought 1,000 shares of common stock – non voting at $44.61.
- His holdings in the class rose to 3,906 shares.
- He reported 406 shares of common stock – voting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Utexo Mint open beta: Get early access to USD₮ on the bitcoin blockchain
"Demand destruction" and tug-of-war over Saudi attack risks, international oil prices fall more than 2%
Traders weighed the impact of Saudi attack risks and sharply reduced demand, causing oil prices to fall more than 2%.
JPMorgan maintains "Neutral" rating on Johnson & Johnson (JNJ.US): Strong data from two anti-cancer drugs, but valuation premium limits upside potential
Johnson & Johnson’s new prostate cancer drug and head and neck cancer drug Ervantumab both released positive data at ESMO. JPMorgan stated that the pipeline shows differentiated potential but valuations are relatively high, maintaining a Neutral rating.
AI trading hype fades and product competition intensifies: SK Hynix (SKHY.US) leveraged ETF delisted from US stock market and liquidated just three months after launch
Two U.S. leveraged ETFs linked to SK Hynix (SKHY.US)—the Tradr 2X Long SK Hynix Daily ETF and the Tradr 2X Short SK Hynix Daily ETF—will be liquidated around November 12, approximately three months after their listing on July 28.
Crypto prices
More
